Bio-Rad - Preparing for a Stress-free QC Audit

GoMeyra LIMS adds new laboratory test panels including Monkeypox

GoMeyra, a cloud-based SaaS company dedicated to providing innovative, real-time software for the healthcare industry, has expanded its innovative GoMeyra LIMS platform. The software is now capable of processing individual tests and panels for monkeypox, urinary tract infections and sexually transmitted infections, with additional panels to follow.

Similar to the technology developed for diagnosing COVID-19, GoMeyra now helps laboratories automate and streamline testing for a broader range of medical conditions. Using digital scanning to process test samples rather than manually inputting data, GoMeyra LIMS monitors and records the journey of a sample from its receipt at a laboratory through the end of its life cycle. It covers four key stages: Sample Storage, Testing, Reporting and Archiving. By eliminating the need for manual input, GoMeyra LIMS removes the risk of human error and significantly improves turnaround time.

GoMeyra LIMS is an all-inclusive, fully customizable cloud-based SaaS platform. The system helps automate the tracking of inventory, restocking and ordering supplies, and vendor management. Built-in features include automated payment and credit card processing, insurance billing, and real-time revenue reporting. Payment options include Square, Cornerstone, Authorize.Net, PayPal and Stripe. Additionally, GoMeyra LIMS alleviates the time-consuming and burden-
some operation of government reporting with an easy way to generate testing reports unique to individual laboratories.

“Our LIMS has helped so many healthcare providers operate more efficiently during the pandemic, and they have been eagerly awaiting our expansion of the platform’s functionality to process a wider variety of tests. As a testament to the loyalty our system is evoking, client demand became the catalyst in driving new development,” said GoMeyra Founder and Chief Executive Officer, Jaswant S. Tony.

GoMeyra is currently working on introducing even more testing panels to its LIMS, with respiratory and toxicology coming next.

For more information, visit: